Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI [NA]

View source ↗

Summary

This clinical trial update reports an ongoing study evaluating curcumin, resveratrol, and stinging nettle as potential treatments for Gulf War Illness, with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)
  • Resveratrol (resveratrol)
  • Stinging nettle extract (urtica dioica extract)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Gulf War Illness | NA | Status: ACTIVE_NOT_RECRUITING